Pyxis Oncology, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026 with the Securities and Exchange Commission on November 5, 2026, disclosing continued net losses and a significant decline in cash and cash equivalents from the year-end 2025 …
Sabre Corporation filed a Form 8-K with the SEC on November 5, 2026, disclosing the issuance of a press release covering its financial results for the quarter ended September 30, 2026, and announcing an accompanying conference call.
Steven Madden, Ltd. filed a Form 8-K on November 5, 2026, announcing its third-quarter financial results for the fiscal year ending December 31, 2026, and declaring a quarterly cash dividend of $0.21 per share on its common stock.
The Middleby Corporation filed a Form 8-K on November 5, 2026, disclosing that Chief Executive Officer Timothy J. FitzGerald will depart effective March 31, 2027, and that Steven P. Spittle has been promoted to President immediately and will become CEO on April 1, 2027.
Installed Building Products, Inc. filed a Form 8-K on November 5, 2026, reporting third-quarter and nine-month financial results for the period ended September 30, 2026, and announcing a quarterly cash dividend of $0.39 per share.
International Seaways, Inc. filed a Form 8-K on November 5, 2026, announcing its third quarter 2026 earnings release and a combined dividend of $5.05 per share of common stock declared by its Board of Directors.
Teads Holding Co. filed a Form 8-K on November 5, 2026, disclosing the appointment of Michael Coyle as Chief Financial Officer effective November 11, 2026, alongside the release of its financial results for the quarter ended September 30, 2026.
Alnylam Pharmaceuticals, Inc. filed a Form 8-K on November 5, 2026, disclosing a $1.0 billion common stock repurchase program authorized by its Board of Directors on November 2, 2026, and announcing that Executive Vice President and Chief Commercialization Officer Tolga Tanguler will depart the …
Gibraltar Industries, Inc. filed a Form 8-K on November 5, 2026, disclosing the resignation of Chief Financial Officer Joseph A. Lovechio effective November 20, 2026, and the appointment of Jeffrey J. Watorek as Interim Chief Financial Officer and Lori Rizzo as principal accounting officer.
The Wendy's Company filed a Form 8-A12B with the U.S. Securities and Exchange Commission on November 5, 2026, to register Preferred Stock Purchase Rights on The Nasdaq Stock Market LLC.